Amarin Corp. (AMRN) option implied volatility elevated into sharp rally on release of patient study

Amarin Corp. (NASDAQ: AMRN) September weekly call option implied volatility is at 566, October is at 300; compared to its 52-week range of 35 to 428 into the release of an 8,000 patient study started in 2011 for their omega3 pill Vascepa.

You May Also Be Interested In

• Oracle (ORCL) call put ratio 2.3 calls to 1 put with a focus on October calls into quarter results
• ServiceTitan (TTAN) call put ratio 1.6 calls to 1 put into quarter results
• Qualcomm (QCOM) call put ratio 4.8 calls to 1 put with a focus on September 11 weekly calls as share price up 4%